BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Day In Review: Biogen Idec, Inc. (Massachusetts) (BIIB) Buys Cancer Company Conforma Therapeutics Corporation


5/4/2006 2:29:39 PM

May 3, 2006 – Biogen Idec paid $150 million upfront to buy Conforma Therapeutics, which is focused on cancer therapies; MGI Pharma and SuperGen received FDA approval for Dacogen, an injected drug for mylodysplastic syndrome;Hemispherix said that Ampligen was surprisingly effective against chronic fatigue syndrome; Bayer and Onyx announced enrolment has been completed in two Phase III trials of cancer treatment Nexavar; GTx Inc has finished enrolling patients in a Phase III trial of Acapodene, its prostate cancer drug; Human Genome completed a sale-leaseback transaction that will raise $220 million in new cash; PDL BioPharma dropped sharply after releasing its Q1 financial numbers; and NPS Pharma took a hit on news the FDA will require another trial for its osteoporoses drug, Preos. The Centient Biotech 200™ moved up 5 points to 3718.78, a rise of .14%. More details...

Read at ChinaBio Today

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES